JAZZ vs YCBD · P/E 1988, rev $2.28B vs P/E 0.3, rev $16.2M
Jazz Pharmaceuticals PLC (JAZZ) versus cbdMD Inc (YCBD) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
cbdMD Inc (YCBD) is a drug manufacturers - specialty & generic company listed on AMEX.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported YCBD revenue for 2026-06-30 was $16.2M. Net income was -$2.2M. Revenue was up 52.1% from 2026-03-31 to 2026-06-30. YCBD currently screens at market cap $7.2M and trailing P/E 0.3.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. YCBD currently screens at market cap $7.2M and trailing P/E 0.3.
Not investment advice. Open the JAZZ and YCBD stock pages for the full models.
Not investment advice.